Relevant Intellectual Property: (1) A comprehensive behavioral, psychosocial,
and life-style assessment tool based on evidence of molecular changes in neuroendocrine hormones, cytokines, inflammatory mediators, and other relevant disease-predicting molecules; (2) A cardiovascular risk- assessment genomics/proteomics tool for evaluating chronic disease progression and efficacy of interventions- similar tool in process for cancer risk assessment; (3) pharmaceutical-grade nutritional supplement product line, particularly for recovery from cancer and other chronic diseases; (4) nasal drug-delivery device (shared IP).